MIST Latest Headlines

Regulatory Disruptions Pose Material Operational Risks for Milestone Pharmaceuticals

at www.tipranks.com (Sat, 21-Mar 2:01 AM)

Milestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target

at www.tipranks.com (Fri, 20-Mar 12:35 PM)

Milestone Advances CARDAMYST Launch After Landmark PSVT Approval and Bolsters Cash Runway

at www.tipranks.com (Fri, 20-Mar 9:08 AM)

Milestone Pharmaceuticals GAAP EPS of -$0.75, revenue of $1.55M

at seekingalpha.com (Fri, 20-Mar 8:05 AM)

Options Volatility and Implied Earnings Moves Today, March 20, 2026

at www.tipranks.com (Fri, 20-Mar 8:05 AM)

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

at www.benzinga.com (Fri, 20-Mar 2:23 AM)

Here are the major earnings before the open Friday

at seekingalpha.com (Thu, 19-Mar 6:00 PM)